Alterations in the Wnt pathway are an initial event in the adenoma-carcinoma progression, predominantly due to mutations in the APC (40.3% to 80.0%) followed by the CTNNB1 gene (11.9–20.0%) [43–45]. Here, CTNNB1 is linked to adenoma.